| 1 |
International Study of Kidney Disease. Minimal change nephritic syndrome in children: deaths during the first 5 to 15 years 'observation. Report of the International Study of Kidney Disease in Children [J]. Pediatrics,1984,73(4):497-501.
|
| 2 |
Nolasco F, Cameron JS, Heywood EF, et al. Adult-onset nephritic syndrome: a long-term follow-up [J]. Kidney Int, 1986, 29(6):1215-1223.
|
| 3 |
Matsumoto H, Nakao T, Okada T, et al. Favorable outcome of low dose cyclosporine after pulse methylprednisolone in Japanese adult minimal-change nephritic syndrome [J]. Intern Med, 2004, 43(8):668-673.
|
| 4 |
Eguchi A, Takei T, Yoshida T, et al. Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome [J]. Nephrol Dial Transplant,2010,25(1):124-129.
|
| 5 |
Chan MK, Cheng IK. Cyclosporine A in steroid sensitive nephrotic syndrome with frequent Relapses [J]. Postgrad Med J, 1987, 63(743):757-759.
|
| 6 |
Clasen W, Kindler J, Mihatsch MJ, et al. Long-term treatment of minimal change nephrotic syndrome with cyclosporine: a control biopsy study[J]. Nephrol Dial Transplant,1988,3(6):733-777.
|
| 7 |
Ghiggeri GM, Catarsi P, Scolari F, et al. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label,nonrandomized, retrospective study [J]. Clin Ther,2004,26(9):1411-1418.
|
| 8 |
Cattran DC, Appel GB, Hebert LA, et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis[J]. Kidney Int,1999,56(6):2220-2226.
|
| 9 |
Gipson DS, Trachtman H, Kaskel FJ, et al. Clinical trial of focal segmental glomerulosclerosis in children and young adults [J].Kidney Int,2011,80(8):868-878.
|
| 10 |
Heering P, Braun N, Mullejans R, et al. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis [J]. Am J Kidney Dis,2004,43(1):10-18.
|
| 11 |
Segarra Medrano A, Vila Presas J, Pou Clavé L, et al. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy inpatientswithcyclosporin-resistantfocalsegmental glomerulosclerosis [J]. Nefrologia,2011,31(3):286-291.
|
| 12 |
Hogg RJ, Friedman A, Greene T, et al. Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS [J]. Clin J Am Soc Nephrol,2013,8(2):211-2118.
|
| 13 |
Cameron JS, Healy MJ, Adu D. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults [J]. Q J Med,1990,74(274):133-156.
|
| 14 |
Cattran DC, Delmore T, Roscoe J, et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy [J]. N Engl J Med,1989,320(4):210-215.
|
| 15 |
Eriguchi M, Oka H, Mizobuchi T, et al. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone [J]. Nephrol Dial Transplant,2009,24(10):3082-3088.
|
| 16 |
Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan [J]. Kidney Int,2004,65(4):1400-1407.
|
| 17 |
葛晓,王艳丽,杨莉娅,等.环孢素A 治疗特发性膜性肾病的荟萃分析[J].临床荟萃,2012,27(3):196-201
|
| 18 |
Cattran DC, Appel GB, Hebert LA, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial[J]. Kidney Int,2001,59(4):1484-1490.
|
| 19 |
Cattran DC, Greenwood C, Ritchie S, et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy[J]. Kidney Int,1995,47(4):1130-1135.
|
| 20 |
Alexopoulos E, Papagianni A, Tsamelashvili M, et al. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome [ J]. Nephrol Dial Transplant,2006,21(11):3127-3132.
|
| 21 |
Shin DH, Lee MJ, Oh HJ, et al. Stepwise treatment using corticosteroids alone and incombination with cyclosporine in Korean patients with idiopathic membranous nephropathy [J]. Yonsei Med J,2013,54(4):973-982.
|
| 22 |
Goumenos DS, Katopodis KP, Passadakis P, et al. Corticosteroids and cyclosporin A in idiopathic membraneous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs [J]. Am J Nephrol,2007,27(3):226-231.
|
| 23 |
Fritsche L, Budde K, Farber L, et al. Treatment of membranous glomerulonephropathy with cyclosporin A: how much patience is required [J]? Nephrol Dial Transplant,1999,14(4):1036-1038.
|
| 24 |
Ambalavanan S, Fauvel JP, Sibley RK, et al. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy[J]. J Am Soc Nephrol,1996,7(2):290-298.
|
| 25 |
Rostoker G, Belghiti D, Ben Maadi A, et al. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy [J].Nephron,1993,63(3):335-361.
|
| 26 |
Saito T, Iwano M, Matsumoto K, et al. Significance of combined cyclosporine-prednisolone therapyandcyclosporineblood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial [J]. Clin Exp Nephrol, 2013, [Epub ahead of print].
|
| 27 |
Cattran DC, Alexopoulos E, Heering P, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome:workshop recommendations [J]. Kidney Int,2007,72(12): 1429-1447.
|
| 28 |
Lai KN, Lai FM, Li PK, et al. Cyclosporin treatment of IgA nephropathy: a short term controlled trial [J]. Br Med J, 1987,295(6607):1165-1168.
|
| 29 |
Chabova V, Tesar V, Zabka J, et al. Long-term treatment of IgA nephropathy with cyclosporin A-a preliminary report [J]. Nephrol Dial Transplant,1997,12(10):2206-2207.
|
| 30 |
Shin JI, Lim BJ, Kim PK, et al. Effects of cyclosporin A therapy combined with steroids and angiotensin converting enzyme inhibitors on childhood IgA nephropathy [J]. J Korean Med Sci, 2010, 25(5):723-727.
|
| 31 |
Liu H, Xu X, Fang Y, et al. Comparison of glucocorticoids alone and combined with cyclosporine a in patients with IgA nephropathy:a prospective randomized controlled trial[J]. Intern Med,2014,53(7):675-681.
|
| 32 |
Lim BJ, Kim JH, Hong SW, et al. Expression of fibrosis-associated molecules in IgA nephropathy treated with cyclosporine [J]. Pediatr Nephrol,2009,24(3):513-519.
|
| 33 |
Kidney Disease: Improving Global Outcomes ( KDIGO )Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis [J]. Kidney Int Suppl, 2012, 2(2): 139-274.
|
| 34 |
Someya T, Kaneko K, Fujinaga S, et al. Cyclosporine A for heavy proteinuria in a child with Henoch-Schönlein purpura nephritis [J].Pediatr Int,2004,46(1):111-113.
|
| 35 |
Shin JI, Park JM, Shin YH, et al. Cyclosporin A therapy for severe Henoch-Schönlein nephritis with nephrotic syndrome [J]. Pediatr Nephrol,2005,20(8):1093-1097.
|
| 36 |
Shin JI, Park JM, Shin YH, et al. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment [J].Scand J Rheumatol,2005,34(5):392-395.
|
| 37 |
Ronkainen J, Autio-Harmainen H, Nuutinen M. Cyclosporin A for the treatment of severe Henoch-Schönlein glomerulonephritis [J].Pediatr Nephrol,2003,18(11):1138-1142.
|
| 38 |
Jee MP,Sung CW,Jae IS,et al. Cyclosporin A therapy for Henoch-Schönlein nephritis with nephrotic-range proteinuria [J]. Pediatr Nephrol,2011,26 (3):411-417.
|
| 39 |
Jauhola O,Ronkainen J,Autio-Harmainen H,et al. Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial [J]. Pediatr Nephrol, 2011, 26(12): 2159-2166.
|
| 40 |
Ohara S,Kawasaki Y,Miyazaki K, et al. Efficacy of cyclosporine A for steroid-resistant severe Henoch-Schönlein purpura nephritis.Fukushima J Med Sci,2013,59(2):102-107.
|
| 41 |
中华医学会儿科学分会肾脏病学组. 儿童常见肾脏疾病诊治循证指南(二):紫癜性肾炎的诊治循证指南(试行)[J].中华儿科杂志,2009,47(12):911-913.
|
| 42 |
Isenberg DA, Snaith ML, Morrow WJ, et al. Cyclosporin A for the treatment of systemic lupus erythematosus [ J ]. Int J Immunopharmacol,1981,3(2):163-169.
|
| 43 |
Favre H, Miescher PA, Huang YP, et al. Cyclosporin in the treatment of lupus nephritis [J]. Am J Nephrol,1989,9(Suppl):57-60.
|
| 44 |
Kamijo Y, Hashimoto K, Takahashi K, et al. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis [J]. Clin Nephrol, 2011,76(2):136-143.
|
| 45 |
Kawasaki Y, Hosoya M, Takano K, et al. Efficacy of cyclosporine therapy for systemic lupus erythematosus in childhood [J]. Pediatr Int,2008,50(2):257-259.
|
| 46 |
Suzuki K, Tanaka H, Tsugawa K, et al. Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy [J]. Tohoku J Exp Med,2006,208(4):355-359.
|
| 47 |
Tam LS, Li EK, Szeto CC, et al. Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A [J].Lupus,2001,10(11):827-829.
|
| 48 |
Hu W, Liu Z, Shen S, et al. Cyclosporine A in treatment of membranous lupus nephropathy [J]. Chin Med J,2003,116(12):1827-1830.
|
| 49 |
Austin HA III, Illei GG, Braun MJ, et al. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy [J]. J Am Soc Nephrol, 2009, 20(4):901-911.
|
| 50 |
Zavada J, Pesickova S, Rysava R, et al. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study [J]. Lupus,2010,19(11):1281-1289.
|
| 51 |
Moroni G, Doria A, Mosca M, et al. A randomized pilot trial comparing cyclosporine versus azathioprine for maintenance therapy in diffuse lupus nephritis over four years [J]. Clin J Am Soc Nephrol,2006,1(5):925-932.
|
| 52 |
Tam LS, Li EK, Leung CB, et al. Long-term treatment of lupus nephritis with cyclosporin A [J]. Q J Med, 1998, 91(8): 573-580.
|
| 53 |
Ogawa H, Kameda H, Nagasawa H, et al. Prospective study of low dose cyclosporine A in patients with refractory lupus nephritis [J].Mod Rheumatol,2007,17(2):92-97.
|
| 54 |
Dostál C, Tesar V, Rychlík I, et al. Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study[J]. Lupus,1998,7(1):29-36.
|
| 55 |
Rihova Z, Vankova Z, Maixnerova D, et al. Treatment of lupus nephritis with cyclosporine-an outcome analysis [J]. Kidney Blood Press Res,2007,30(2):124-128.
|
| 56 |
Fu LW, Yang LY, Chen WP, et al. Clinical efficacy of cyclosporin A Neoral in the treatment of paediatric lupus nephritis with heavy proteinuria [J]. Br J Rheumatol,1998,37(2):217-221.
|
| 57 |
Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association ( EULAR/ERAEDTA) recommendations for the management of adult and paediatric lupus nephritis [J]. Ann Rheum Dis,2012,71(11):1771-1782.
|
| 58 |
李芹,赵秀杰,唐绍芬,等. 环孢素A 人体药动学影响因素分析[J].中国医院药学杂志,2002,2-2(7):431.
|
| 59 |
Oellerich M, Armstrong VW. Two-hour cyclosporine concentration determination: an appropriate tool to monitor neural therapy [J].Ther Drug Monit,2002,24(1):40-46.
|
| 60 |
Johnston A, Chusney G, Schǜtz E, et al. Monitoring cyclosporin in blood: between-assay differences at trough and 2 hours post-dose(C2) [J]. Ther Drug Monit,2003,25(2):167-173.
|
| 61 |
Keown PA. New concepts in cyclosporine monitoring[J]. Curr Opin Nephrol Hypertens,2002,11(6):619-629.
|
| 62 |
邵丽佳,徐瑞龙,朱以军,等. 肾移植患者口服环孢素A 的血药浓度监测分析. 中国现代应用药学杂志,2007,24(3):247.
|
| 63 |
Camara NO, Matos AC, Rodrigues DA, et al. Early detection of heart transplant patients with increased risk of cyclosporin nephrotoxicity [J]. Lancet,2001,357(9259):856-857.
|
| 64 |
Kahan BD. Therapeutic drug monitoring of cyclosporine:20 years of progress. Transplant Proc,2004,36(2 Suppl):378S-391S.
|
| 65 |
万元胜,师少军,吴伶,等. 环孢素A 血药浓度影响因素综述[J].西部流行病学杂志,2006,15(3):152-154.
|
| 66 |
Dawidson I, Rooth P, Alway C, et al. Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity[J]. Transplant Proc,1990,22(4):1379-1380.
|
| 67 |
Kessler M, Netter P, Renoult E, et al. Influence of nicardipine on renal function and plasma cyclosporin in renal transplant patients[J]. Eur J Clin Pharmacol,1989,36(6):637-638.
|
| 68 |
Ichikawa I. Will angiotensin Ⅱ receptor antagonists be renoprotective in humans [J]? Kidney Int, 1996, 50(2): 684-692.
|
| 69 |
Burdmann EA, Andoh TF, Nast CC, et al. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril [J]. Am J Physiol,1995,269(4 Pt 2): F491-F499.
|